Clay Siegall is one of the brains behind the inception of Seattle Genetics, a leading company in the development of antibody drug conjugates. For this reason, he has managed to create a name for himself in the cancer research community. Away from his executive responsibilities as the CEO and president of Seattle Genetics, Clay operates his blog called Clay Siegall blog on WordPress.com.
Through his WordPress blog, Clay has availed a wide range of information for his audience. Mostly, his posts are derived from information provided by the National Public Radio (NPR). His recent post involves details about how a paralyzed man utilizes his thoughts to control the movement of his arm and hand. Away from science clay’s other posts relate to sports, agriculture, politics in the US and animals among other topics.
As a person who is significantly involved in cancer research, Clay displays his passion through posts regarding studies and developments in the cancer research community. One of the posts includes the March 23, 2017 post about a study that found out that bad luck partly causes cancer.
A Close Focus on Clay Siegall
Since co-founding Seattle Genetics in 1998, Clay Siegall has been serving as the company’s CEO, president and chairperson of the board to date. He is an acclaimed scientist in the cancer research community with specialization on targeted cancer therapies. Clay established the company on a foundation of rigorous research, drug development scientific innovation practices coupled with his commitment to helping patients. Under his leadership, he has helped steer the company to its leadership position in attaining the 2011 FDA approval for ADCETRIS and creating antibody-drug conjugates.
Clay Siegall is acknowledged for leading Seattle Genetics into multiple strategic licenses specifically for its antibody-drug conjugates technology. The licenses involve companies like Pfizer, GlaxoSmithKline, Genentech and AbbVie, which have generated over $350 million to this day. Siegall is well-educated and boasts of a B.S in Zoology and a Ph.D. in Genetics from the renowned University of Maryland and the George Washington University respectively. He has also won several accolades including the Pacific Northwest Ernst & Young Entrepreneur of the year in 2012.